Repaglinide: A Review of its Therapeutic Use in Type 2 Diabetes Mellitus

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.11, 2001-01, pp. : 1625-1660

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Repaglinide: A Pharmacoeconomic Review of its Use in Type 2 Diabetes Mellitus

By Plosker G.L. Figgitt D.P.

PharmacoEconomics, Vol. 22, Iss. 6, 2004-01 ,pp. : 389-411

Adis International

Access to resources Recommend Favorite

Repaglinide: A Review of Its Use in Type 2 Diabetes Mellitus

By Scott Lesley J.

Drugs, Vol. 72, Iss. 2, 2012-01 ,pp. : 249-272

Adis International

Access to resources Recommend Favorite

Defining the Role of Repaglinide in the Management of Type 2 Diabetes Mellitus: A Review

By Odd Erik Johansen

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 5, 2007-01 ,pp. : 319-335

Adis International

Access to resources Recommend Favorite

Insulin Glargine: A Review of its Therapeutic Use as a Long-Acting Agent for the Management of Type 1 and 2 Diabetes Mellitus

By McKeage K. Goa K.L.

Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. : 1599-1624

Adis International

Access to resources Recommend Favorite

Miglitol: A Review of its Therapeutic Potential in Type 2 Diabetes Mellitus

By Scott L.J. Spencer C.M.

Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. : 521-549

Adis International

Access to resources Recommend Favorite